Regulatory T Cells in Inflammation
Autor Corporativo: | |
---|---|
Otros Autores: | , , |
Formato: | eBook |
Lenguaje: | English |
Publicado: |
Basel :
Birkhäuser Basel : Imprint: Birkhäuser,
2005.
|
Edición: | 1st ed. 2005. |
Colección: | Progress in Inflammation Research,
|
Materias: | |
Acceso en línea: | https://doi.org/10.1007/b137037 |
Tabla de Contenidos:
- Origin, function and distribution of regulatory T cells
- History of CD25+CD4+ regulatory T cells
- “Natural” and “induced” regulatory T cells — purpose and problems associated with an emerging distinction
- The role of interleukin-10 in regulatory-T-cell suppression: reconciling the discrepancies
- Activation and distribution of regulatory T cells in naïve and antigen-stimulated immune systems
- Regulatory T cells and the innate immune system
- The potential use of regulatory T cells in immunotherapy
- Exploiting the potential of regulatory T cells in the control of type 1 diabetes
- Regulatory T cells in type 1 autoimmune diabetes
- The potential for targeting CD4+CD25+ regulatory T cells in the treatment of multiple sclerosis in humans
- Immunotherapy of rheumatoid arthritis using CD4+CD25+ regulatory T cells
- Potential for manipulation of regulatory T cells in treatment or prevention of allergic disease
- The role of regulatory T cells in cutaneous disorders
- The potential role of CD25+CD4+ regulatory T cells in the induction and maintenance of transplantation tolerance in humans.